Regulus: Shares should double , maybe triple in the next six weeks !

It has seemed to have been an eternity since the FDA placed rg-101 on a clinical hold. Regulus has stated they will provide a complete response letter to all of the questions and information requested by the FDA early in the fourth quarter 2016. The FDA then has thirty days to respond to the companies […]
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.